Keywords: bzl101, advance, into, ph, ii, trials, drug

BZL101 to advance into US Ph II trials this year

Article | 09 June 2008

Print This

US drug developer Bionovo reported encouraging data from an ongoing trial of BZL101, an oral drug candidate, in patients with ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in